Moreover, expression of a dominant negative, kinase-defective Src mutant resulted in increased sensitivity to oxaliplatin-mediated apoptosis in KM12L4 human colon tumor cells in vitro [21]. This evidence concerns the gene SRC and colonic neoplasm.